Biotech News News and Resources

Biotech News

BioNTech Completes Acquisition of Biotheus

BioNTech SE has finalised its acquisition of Biotheus, a clinical-stage biotechnology company focused on novel antibody development for oncology and inflammatory diseases. The transaction, initially announced in November 2024, enhances BioNTech’s research and development capabilities, particularly in bispecific antibodies. The

Read More »
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.